Phase 3 Readout~month

Phase 3 Topline: A Phase II/III Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Effi

Indication
Chronic Spontaneous Urticaria (CSU)

Other upcoming events for TECH

Phase 3 ReadoutPhase 3 Topline: A Randomized, Double-blind, Placebo-controlled Phase III Study Evaluating the Efficacy and Safety of
Phase 3 ReadoutPhase 3 Topline: A Randomized, Controlled, Open-label, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: A Phase II/III Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Effi — TECH Phase 3 Readout | BioSniper